Study of a new medicine for chronic kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new medicine called HS-10390 to see if it can help people with chronic kidney disease. It might slow down the disease and protect your kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- Your kidney function is moderately reduced (eGFR between 30 and 90).
- You have protein in your urine (UACR between 300 and 3000 mg/g).
- You are already taking a stable dose of blood pressure medicine (ACEI or ARB) for at least 3 months.
- Your blood pressure is not too high or too low (systolic 90-160, diastolic 60-100).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, SAL0140, at different doses to see if it can help people with chronic kidney disease. It may reduce protein in the urine, which is a sign of kidney damage.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests a new daily pill (called HRS-7535) that may help protect kidney function in people with chronic kidney disease. It works like a natural hormone to help control blood sugar and reduce inflammation, and the researchers want to see if it can slow down kidney damage.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests an investigational drug called IGT-303 in people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and helpful for slowing kidney damage.
This trial tests a new medicine called HS-10390 to see if it can help people with IgA nephropathy, a kidney disease. It aims to reduce protein in the urine and protect kidney function.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.